Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
---|---|---|---|---|---|
Income Statement | |||||
Total Revenue | 1.43B | 1.31B | 1.06B | 892.25M | 607.64M |
Gross Profit | 1.18B | 1.11B | 878.53M | 723.38M | 541.79M |
EBITDA | -145.34M | -141.70M | -329.56M | -486.24M | -90.72M |
Net Income | -73.69M | -89.88M | -328.35M | -525.59M | -92.39M |
Balance Sheet | |||||
Total Assets | 2.87B | 2.95B | 2.74B | 2.57B | 866.46M |
Cash, Cash Equivalents and Short-Term Investments | 1.63B | 1.88B | 1.76B | 1.87B | 460.52M |
Total Debt | 77.82M | 67.07M | 63.44M | 51.40M | 20.08M |
Total Liabilities | 1.02B | 938.64M | 815.05M | 650.53M | 1.67B |
Stockholders Equity | 1.85B | 2.02B | 1.92B | 1.92B | -803.70M |
Cash Flow | |||||
Free Cash Flow | 305.64M | 291.74M | -33.80M | -68.02M | 25.98M |
Operating Cash Flow | 320.56M | 299.08M | -9.98M | -54.96M | 29.18M |
Investing Cash Flow | -45.50M | -439.57M | -289.14M | -35.44M | -125.99M |
Financing Cash Flow | -450.51M | -196.90M | -60.67M | 1.47B | 250.42M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
74 Outperform | $4.81B | 19.73 | 19.09% | ― | 11.22% | 40.85% | |
72 Outperform | $8.63B | 5,259.57 | -0.32% | ― | 1.16% | -104.62% | |
69 Neutral | $5.74B | ― | -3.62% | ― | 7.21% | 23.13% | |
68 Neutral | $6.28B | 4,590.48 | 0.10% | ― | 9.60% | -90.58% | |
64 Neutral | $5.51B | ― | -26.98% | ― | 28.19% | -31.34% | |
61 Neutral | $36.30B | 7.26 | -7.27% | 1.97% | 7.74% | -7.92% | |
57 Neutral | $6.15B | ― | -32.18% | ― | 23.02% | 21.01% |
On June 26, 2025, UiPath, Inc. held its annual stockholders meeting where 94.53% of voting power was represented. During the meeting, stockholders approved three key proposals: the election of eight directors, a non-binding advisory vote on executive compensation, and the ratification of KPMG LLP as the independent auditor for the fiscal year ending January 31, 2026.
The most recent analyst rating on (PATH) stock is a Hold with a $16.00 price target. To see the full list of analyst forecasts on UiPath stock, see the PATH Stock Forecast page.